RESEARCH DETAILS

Aspirin, inflammation markers, and colorectal adenoma

Description:
This is an ancillary study in the Aspirin/Folate Polyp Prevention Study, a trial of aspirin (and folate) as a chemopreventive agent against recurrence colorectal adenomas. The major goal of this ancillary study is to examine if plasma levels of inflammatory markers (TNF-a, IL-6, and CRP) are associated with the risk of colorectal adenoma and whether low-dose aspirin reduces the levels of these proinflammatory markers.

Categories:
Cancer; Molecular Epidemiology
Principal Investigator:
Gloria Y.F. Ho, PhD, MPH <i>(voluntary appt)</i>
Co-Investigators:
Xiaonan (Nan) Xue, PhD

Funding Agency:
National Cancer Institute
Start Date:
7/1/2004
End Date:
12/31/2007

Associated division for this research project: Epidemiology